Patients’ clinicopathological features
| Characteristics . | All, N = 54 n (%) . | nt-FL, n = 34 n (%) . | st-FL, n = 20 n (%) . | P . |
|---|---|---|---|---|
| Sex | NS | |||
| Male | 27 (50) | 16 (47) | 11 (55) | |
| Female | 27 (50) | 18 (53) | 9 (45) | |
| Age at FL diagnosis, y | NS | |||
| Median | 54 | 54 | 54 | |
| Range | 35-78 | 35-76 | 40-78 | |
| Ann Arbor stage | .014 | |||
| I-II | 17 (26) | 15 (44) | 2 (10) | |
| III-IV | 35 (71) | 18 (53) | 17 (85) | |
| Unknown | 2 (3) | 1 (3) | 1 (5) | |
| FLIPI | .012 | |||
| Low | 24 (37) | 20 (59) | 4 (20) | |
| Intermediate | 19 (28) | 10 (29) | 9 (45) | |
| High | 7 (29) | 2 (6) | 5 (25) | |
| Unknown | 4 (6) | 2 (6) | 2 (10) | |
| LDH elevation | NS | |||
| Yes | 2 (12) | 1 (3) | 1 (5) | |
| No | 48 (82) | 31 (91) | 17 (85) | |
| Unknown | 4 (6) | 2 (6) | 2 (10) | |
| B-symptoms | NS | |||
| Yes | 12 (23) | 6 (18) | 6 (30) | |
| No | 39 (72) | 27 (79) | 12 (60) | |
| Unknown | 3 (6) | 1 (3) | 2 (10) | |
| Performance score | NS | |||
| <2 | 41 (75) | 28 (82) | 13 (65) | |
| ≥2 | 10 (20) | 5 (15) | 5 (25) | |
| Unknown | 3 (5) | 1 (3) | 2 (10) | |
| Bone marrow involvement | NS | |||
| Yes | 14 (31) | 6 (18) | 8 (40) | |
| No | 33 (55) | 24 (71) | 9 (45) | |
| Unknown | 7 (14) | 4 (12) | 3 (15) | |
| Anemia | NS | |||
| Yes | 4 (8) | 1 (3) | 3 (15) | |
| No | 47 (88) | 32 (94) | 15 (75) | |
| Unknown | 3 (5) | 1 (3) | 2 (10) | |
| FL histology | NS | |||
| FL grade 1-2 | 46 (86) | 29 (85) | 17 (85) | |
| FL grade 3A | 8 (14) | 5 (15) | 3 (15) |
| Characteristics . | All, N = 54 n (%) . | nt-FL, n = 34 n (%) . | st-FL, n = 20 n (%) . | P . |
|---|---|---|---|---|
| Sex | NS | |||
| Male | 27 (50) | 16 (47) | 11 (55) | |
| Female | 27 (50) | 18 (53) | 9 (45) | |
| Age at FL diagnosis, y | NS | |||
| Median | 54 | 54 | 54 | |
| Range | 35-78 | 35-76 | 40-78 | |
| Ann Arbor stage | .014 | |||
| I-II | 17 (26) | 15 (44) | 2 (10) | |
| III-IV | 35 (71) | 18 (53) | 17 (85) | |
| Unknown | 2 (3) | 1 (3) | 1 (5) | |
| FLIPI | .012 | |||
| Low | 24 (37) | 20 (59) | 4 (20) | |
| Intermediate | 19 (28) | 10 (29) | 9 (45) | |
| High | 7 (29) | 2 (6) | 5 (25) | |
| Unknown | 4 (6) | 2 (6) | 2 (10) | |
| LDH elevation | NS | |||
| Yes | 2 (12) | 1 (3) | 1 (5) | |
| No | 48 (82) | 31 (91) | 17 (85) | |
| Unknown | 4 (6) | 2 (6) | 2 (10) | |
| B-symptoms | NS | |||
| Yes | 12 (23) | 6 (18) | 6 (30) | |
| No | 39 (72) | 27 (79) | 12 (60) | |
| Unknown | 3 (6) | 1 (3) | 2 (10) | |
| Performance score | NS | |||
| <2 | 41 (75) | 28 (82) | 13 (65) | |
| ≥2 | 10 (20) | 5 (15) | 5 (25) | |
| Unknown | 3 (5) | 1 (3) | 2 (10) | |
| Bone marrow involvement | NS | |||
| Yes | 14 (31) | 6 (18) | 8 (40) | |
| No | 33 (55) | 24 (71) | 9 (45) | |
| Unknown | 7 (14) | 4 (12) | 3 (15) | |
| Anemia | NS | |||
| Yes | 4 (8) | 1 (3) | 3 (15) | |
| No | 47 (88) | 32 (94) | 15 (75) | |
| Unknown | 3 (5) | 1 (3) | 2 (10) | |
| FL histology | NS | |||
| FL grade 1-2 | 46 (86) | 29 (85) | 17 (85) | |
| FL grade 3A | 8 (14) | 5 (15) | 3 (15) |
P values in bold are significant. FLIPI, follicular lymphoma international prognostic index; LDH, lactate dehydrogenase; NS, not significant.